Stanford University Cancer Institute is a clinical research site located in Palo Alto, California, United States 94305.
Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
Stanford University Cancer Institute has participated in 4 clinical trials.
Therapeutic areas: Melanoma, Skin, Hematological Malignancies, Glioblastoma Multiforme.
Sponsors: Stanford University, Gamida Cell ltd, NovoCure Ltd..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in California · View every site in Palo Alto
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Stanford University Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Stanford University Cancer Institute has 4 clinical trials on record. Their work covers Melanoma, Skin, Hematological Malignancies, Glioblastoma Multiforme.
Stanford University Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.